Everything below concerns research chemical. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
== Eluotropic series == An eluotropic series is a list of solvents ordered by their eluting power relative to a fixed adsorbent and a fixed analyte. The "eluting power" of a solvent is largely a measure of how well the solvent can "pull" an analyte off the adsorbent to which it is attached. This often happens when the eluent itself adsorbs onto the stationary phase, displacing the analyte. Such series are useful for determining necessary solvents needed for chromatography of chemical compounds. In general, when the adsorbent is polar (as in normal-phase liquid chromatography), the non-polar solvents such as n-hexane have low eluting power, and polar solvents such as ethanol, methanol or water have high eluting power.
All human remains at the site were found to contain "very high levels" of mercury. This is believed to be either due to their continuous exposure to mercury-containing cinnabar or because their skin was painted with mercury. Additionally, evidence of osteoarthritis was found in bones, which may indicate that those humans either walked a lot or were dancers.
In the establishment of the Soviet Union in the former Russian Empire, Bolshevism was the ideological basis. As the only legal vanguard party, it decided almost all policies, which the communist party represented as correct. Because Leninism was the revolutionary means to achieving socialism in the praxis of government, the relationship between ideology and decision-making inclined to pragmatism and most policy decisions were taken in light of the continual and permanent development of Marxism–Leninism, with ideological adaptation to material conditions. The Bolshevik Party lost in the 1917 Russian Constituent Assembly election, obtaining 23.3% of the vote, to the Socialist Revolutionary Party, which obtained 37.6%. On 6 January 1918, the Draft Decree on the Dissolution of the Constituent Assembly was issued by the Central Executive Committee of the Congress of Soviets, a committee dominated by Vladimir Lenin, who had previously supported multi-party free elections. After the Bolshevik defeat, Lenin started referring to the assembly as a "deceptive form of bourgeois-democratic parliamentarism". This was criticised as being the development of vanguardism as a form of hierarchical party–elite that controlled society. Within five years of the death of Lenin, Joseph Stalin completed his rise to power and was the leader of the Soviet Union who theorised and applied the socialist theories of Lenin and Karl Marx as political expediencies used to realise his plans for the Soviet Union and for world socialism.
Sources: en.wikipedia.org
In 1947, Ho Chi Minh and General Võ Nguyên Giáp retreated with his command into the Việt Bắc, the mountainous forests of northern Vietnam. By March, France had taken control of the main population centers in the country. The French chose not to pursue the Việt Minh before the beginning of the seasonal rains in May, and military operations were postponed until their conclusion. Come October, the French launched Operation Léa with the objective of swiftly putting an end to the resistance movement by taking out the Vietnamese main battle units and the Việt Minh leadership at their base in Bắc Kạn. Léa was followed by Operation Ceinture in November, with similar aims. As a result of the French offensive, the Việt Minh would end up losing valuable resources and suffering heavy losses, 7,200–9,500 KIA. Nevertheless, both operations failed to capture Ho Chi Minh and his key lieutenants as intended, and the main Vietnamese battle units managed to survive. In 1948, France started looking for means of opposing the Việt Minh politically, with an alternative government led by former emperor Bảo Đại to lead an "autonomous" government within the French Union of nations. This new state ruled over northern and central Vietnam, excluding the colony of Cochinchina, and had limited autonomy. This initial accord with the French was decried by non-Communist nationalists and Bảo Đại withdrew from the agreement. It would not be until March 1949 that the French would concede on the issue of unification and a final agreement would be reached.
=== 5th generation cephalosporins === Currently there are only two drugs in this category, ceftobiprole and ceftaroline. These new drugs are also the only β-lactam antibiotics that are effective against methicillin-resistant-Staphylococcus-aureus (MRSA). Ceftobiprole is a pyrrolidinone-3-ylidenemethyl cephem. The C-3 side chain was specifically designed to have a strong binding affinity to PBP2a and PBP2x. PBP2a is known to give staphylococci resistance to other β-lactam drugs and PBPx does the same for pneumococci. Ceftobiprole also has an aminothiazoyl-hydroxyimino side chain at the C-7 position which is known to give good resistance to β-lactamase from S. aureus. Together these active groups make ceftobiprole bactericidal to MRSA. Ceftobiprole has poor water solubility and is therefore administered intravenously as an ester prodrug called ceftobiprole medocaril. It is rapidly broken down into active ceftobiprole by plasma esterases. Ceftaroline was developed from the fourth generation cephalosporin cefozopran. It retains the alkoxyimino group at position C-7 from earlier generations so it is fairly stable in the presence of many β-lactamases. Since MRSA and penicillin-resistant Streptococcus pneumoniae have resistance dedicated to new types of PBP, PBP2a and PBP2x respectively, both ceftaroline and ceftobiprole have C-3 side chains specially engineered to bind these new PBP. In the case of ceftaroline this side chain contains a 2-thioazolythio spacer linkage optimised for its anti-MRSA activity.
=== Synergistic toxicity === It has been found that some three-fingered toxins from mamba venom interact synergistically with each other. The molecular mechanisms of these interactions remain unknown. It is not known either whether calciseptine has a synergistic effect with other venom compounds.
Several artificial nucleobases have been synthesized, and successfully incorporated in the eight-base DNA analogue named Hachimoji DNA. Dubbed S, B, P, and Z, these artificial bases are capable of bonding with each other in a predictable way (S–B and P–Z), maintain the double helix structure of DNA, and be transcribed to RNA. Their existence could be seen as an indication that there is nothing special about the four natural nucleobases that evolved on Earth. On the other hand, DNA is tightly related to RNA which does not only act as a transcript of DNA but also performs as molecular machines many tasks in cells. For this purpose it has to fold into a structure. It has been shown that to allow to create all possible structures at least four bases are required for the corresponding RNA, while a higher number is also possible but this would be against the natural principle of least effort.
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.